Champions Oncology (CSBR) EPS (Weighted Average and Diluted) Growth (3y) (2017 - 2026)
Champions Oncology (CSBR) EPS (Weighted Average and Diluted) Growth (3y) (2017 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EPS (Weighted Avg. Diluted) Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
59.54% |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
22,777.33% |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
1,857.10% |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
41.33% |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
14.33% |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
- |
| 10 |
Champions Oncology |
82.77 Mn |
75.76 Mn |
13.89 Mn |
51.93% |
| Date | Value |
|---|
| Jan 31, 2026 |
51.93% |
| Oct 31, 2025 |
166.42% |
| Jul 31, 2025 |
-14.47% |
| Apr 30, 2025 |
-86.63% |
| Jan 31, 2025 |
83.71% |
| Oct 31, 2024 |
35.72% |
| Jul 31, 2024 |
122.40% |
| Apr 30, 2024 |
41.52% |
| Jan 31, 2024 |
-67.68% |
| Oct 31, 2023 |
-1,212.56% |
| Jul 31, 2023 |
-175.89% |
| Apr 30, 2023 |
0.00% |
| Jan 31, 2023 |
-100.00% |
| Oct 31, 2022 |
-27.22% |
| Jul 31, 2022 |
30.66% |
| Apr 30, 2022 |
0.00% |
| Jan 31, 2022 |
54.20% |
| Oct 31, 2021 |
0.00% |
| Jul 31, 2021 |
-31.04% |
| Apr 30, 2021 |
0.00% |
